Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Moderna : Taps Magenta Investments As UAE Distributor For COVID-19 Vaccine

06/15/2021 | 10:04am EDT


ę MT Newswires 2021
All news about MODERNA, INC.
04:49pMODERNA : U.S. administers 348.1 mln doses of COVID-19 vaccines - CDC
RE
04:44pMODERNA : U.S. CDC Says Delivered 402,010,455 Doses Of Covid-19 Vaccine As Of Au..
RE
10:36aMODERNA : Receives FDA Fast Track Designation for Respiratory Syncytial Virus Va..
AQ
08/03MODERNA : U.S. administers 347.4 mln doses of COVID-19 vaccines - CDC
RE
08/03MODERNA : U.S. CDC Says Delivered 401,229,975 Doses Of Covid-19 Vaccine As Of Au..
RE
08/03MODERNA : Covid-19 3rd Wave - Federal Govt Declares Lagos, Akwa Ibom, Rivers, Ka..
AQ
08/03MODERNA : Respiratory Syncytial Virus Vaccine mRNA-1345 Receives FDA Fast-Track ..
MT
08/03Sanofi bets on mRNA vaccines beyond COVID in $3.2 billion Translate Bio deal
RE
08/03MODERNA : Receives FDA Fast Track Designation for Respiratory Syncytial Virus (R..
BU
08/03Moderna, Inc. Receives FDA Fast Track Designation for Respiratory Syncytial V..
CI
More news
Financials (USD)
Sales 2021 19 117 M - -
Net income 2021 10 725 M - -
Net cash 2021 11 948 M - -
P/E ratio 2021 16,6x
Yield 2021 -
Capitalization 168 B 168 B -
EV / Sales 2021 8,18x
EV / Sales 2022 9,29x
Nbr of Employees 1 300
Free-Float 90,3%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Last Close Price 419,05 $
Average target price 187,80 $
Spread / Average Target -55,2%
EPS Revisions
Managers and Directors
StÚphane Bancel Chief Executive Officer & Director
Stephen Hoge President
David W. Meline Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capi. (M$)
MODERNA, INC.269.97%155 195
LONZA GROUP AG26.48%59 070
IQVIA HOLDINGS INC.39.52%47 899
CELLTRION, INC.-24.93%31 463
SEAGEN INC.-9.68%28 780
PHARMARON BEIJING CO., LTD.88.66%25 501